Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Lyophilization of Nanoparticle-Based Formulations

Posted on By

SOP for Lyophilization of Nanoparticle-Based Formulations

Standard Operating Procedure for Lyophilization of Nanoparticle-Based Formulations

1) Purpose

This SOP outlines the procedure for lyophilizing nanoparticle-based formulations, which is used to improve the stability and shelf life of the nanoparticles by removing water through freeze-drying.

2) Scope

This SOP applies to personnel involved in the formulation, preparation, and lyophilization of nanoparticle-based products in pharmaceutical or research laboratories.

3) Responsibilities

  • Operators: Responsible for performing the lyophilization process following this SOP.
  • QA: Ensures the process parameters meet required specifications for nanoparticle stability and quality.

4) Procedure

4.1 Preparation of Nanoparticles

4.1.1 Nanoparticle Formulation

  • 4.1.1.1 Prepare the nanoparticles using solvent evaporation, nanoprecipitation, or other standard methods suitable for the type of nanoparticles being lyophilized.
See also  SOP for High-Pressure Homogenization for Nanoparticle Production

4.1.2 Addition of Cryoprotectants

  • 4.1.2.1 Add cryoprotectants such as trehalose or mannitol to the nanoparticle suspension to prevent aggregation and damage during freeze-drying.
  • 4.1.2.2 Ensure the concentration of the cryoprotectant is optimized based on the type of nanoparticle and its stability requirements.

4.2 Lyophilization Process

4.2.1 Freezing Step

  • 4.2.1.1 Freeze the nanoparticle suspension by placing it in a lyophilizer at a temperature below -40°C to ensure the nanoparticles are completely frozen.

4.2.2 Primary Drying

  • 4.2.2.1 Initiate the primary drying phase by applying a vacuum to the frozen sample to sublimate the water directly from ice to vapor.

4.2.3 Secondary Drying

  • 4.2.3.1 Perform the
secondary drying phase by gradually raising the temperature to remove any bound water, ensuring the nanoparticles remain stable without degradation.

4.3 Post-Lyophilization Testing

4.3.1 Reconstitution and Stability Testing

  • 4.3.1.1 After lyophilization, reconstitute a portion of the nanoparticles in water to test for particle size and zeta potential stability using dynamic light scattering (DLS).

5) Abbreviations, if any

  • DLS: Dynamic Light Scattering

6) Documents, if any

  • Lyophilization Process Logbook

7) References, if any

  • Protocols for freeze-drying of nanoparticles

8) SOP Version

Version 1.0

Annexure

Lyophilization Process Logbook Template

Date Batch Number Cryoprotectant Used Freezing Temperature Particle Size Operator Initials QA Initials
DD/MM/YYYY Batch Number Cryoprotectant Used Temperature (°C) Size in nm Operator Name QA Name
             
See also  SOP for Preparation of Lipid-Based Nanoparticles
Nanoparticle Formulation Tags:Nanoparticle biomedical applications SOP, Nanoparticle clinical trial SOP, Nanoparticle encapsulation SOP, Nanoparticle formulation SOP, Nanoparticle handling SOP, Nanoparticle preparation procedure, Nanoparticle production SOP, Nanoparticle quality control SOP, Nanoparticle size optimization SOP, Nanoparticle SOP, Nanoparticle stability testing SOP, Nanoparticle standard operating procedures, Nanoparticle sterilization SOP, Nanoparticle storage SOP, Nanoparticle surface modification SOP, Nanoparticle synthesis SOP, Nanoparticle toxicology SOP, SOP for nanomaterials, SOP for nanoparticle characterization, SOP for nanoparticle drug delivery, SOP for nanoparticle gene delivery, SOP for nanoparticle regulatory compliance, SOP for nanoparticle safety, SOP for nanoparticle scaling, SOP for targeted drug delivery nanoparticles

Post navigation

Previous Post: SOP for Storage and Handling of Lyophilized Products
Next Post: SOP for Packaging of Lyophilized Products

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version